Stroup M, MacIlroy M Jr. Five examples of an antibody defining an antigen of high frequency in the Caucasian population (conference abstract). 23rd Annual Meeting of the American Association of Blood Banks, San Francisco, CA; 1970:86.Search in Google Scholar
Gellerman M, Stroup M. Unpublished observations, cited in Race RR, Sanger R. Blood groups in man. 6th ed., pp. 441-424 (Blackwell, Oxford 1975).Search in Google Scholar
Miyazaki T, Kwon KW, Yamamoto K, et al. A human monoclonal antibody to high frequency red cell antigen Jra. Vox Sang 1994;66:51–4.10.1111/j.1423-0410.1994.tb00277.xSearch in Google Scholar
Nakajima H, Ito K. An example of anti-Jracausing hemolytic disease of the newborn and frequency of Jraantigen in the Japanese population. Vox Sang 1978;35:265–7.10.1111/j.1423-0410.1978.tb02932.xSearch in Google Scholar
Okubo Y. Some rare blood group phenotypes in Japanese, Fy(a–), Di(b–) and Jr(a–) (in Japanese). Blood Programme 1978;1:279–84.Search in Google Scholar
Tritchler JE. An example of anti-Jra. Transfusion 1977;17: 177–8.10.1046/j.1537-2995.1977.17277151926.xSearch in Google Scholar
Kendal AG. Clinical importance of the rare erythrocyte antibody anti-Jra. Transfusion 1976;16:646–7.10.1046/j.1537-2995.1976.16677060250.xSearch in Google Scholar
Levene C, Sela R, Dvilansky A, Yermiahu T, Daniels G. The Jr(a–) phenotype and anti-Jrain two Beduin Arab women in Israel. Transfusion 1986;26:119–20.10.1046/j.1537-2995.1986.26186124019.xSearch in Google Scholar
Vedo M, Reid ME. Anti-Jrain a Mexican American. Transfusion 1978;18:569.10.1046/j.1537-2995.1978.18579036387.xSearch in Google Scholar
Yamaguchi H, Okubo Y, Seno T, et al. A rare phenotype blood Jr(a–) occurring in two successive generations of a Japanese family. Proc Jpn Acad 1976;52:521–3.10.2183/pjab1945.52.521Search in Google Scholar
Orrick LR, Golde SH. Jramediated hemolytic disease of the newborn infant. Am J Obstet Gynecol 1980;137:135–6.10.1016/0002-9378(80)90397-XSearch in Google Scholar
Toy P, Reid M, Lewis T, Ellisor S, Avoy DR. Does anti-Jracause hemolytic disease of the newborn? Vox Sang 1981;41:40–4.10.1159/000460612Search in Google Scholar
Bacon J, Sherrin D, Wright RG. Case report, anti-Jra(letter). Transfusion 1986;26:543–4.10.1046/j.1537-2995.1986.26687043624.x3775839Search in Google Scholar
Bellver-Pradas J, Arriaga-Chafer F, Perales-Marin A, Maisques-Montesinos V, Serra-Serra V. Obstetric significance of anti-Jra. Am J Obstet Gynecol 2001;184:75–6.10.1067/mob.2001.10778711174483Search in Google Scholar
Ishihara Y, Miyata S, Chiba Y, Kawai T. Successful treatment of extremely severe fetal anemia due to anti-Jraalloimmunization. Fetal Diagn Ther 2006;21:269–71.10.1159/00009135416601336Search in Google Scholar
Peyrard T, Pham BN, Arnaud L, et al. Obstetric significance of anti-Jra: study of twenty pregnancy outcomes showing three cases of severe hemolytic disease of the fetus and newborn (abstract). Transfusion 2008;48(Suppl):14A.10.1111/j.1537-2995.2008.01787.x18522708Search in Google Scholar
Peyrard T, Pham BN, Arnaud L, et al. Fatal hemolytic disease of the fetus and newborn associated with anti-Jra. Transfusion 2008;48:1906–11.10.1111/j.1537-2995.2008.01787.xSearch in Google Scholar
Arriaga F, Gomez I, Lineares MD, Gascon A, Carpio N, Perales A. Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jra(letter). Transfusion 2009;49:813.10.1111/j.1537-2995.2008.02087.x19335378Search in Google Scholar
Masumoto A, Masuyama H, Sumida Y, Segawa T, Hiramatsu Y. Successful management of anti-Jraalloimmunization in pregnancy: a case report. Gynecol Obstet Invest 2010;69:81–3.10.1159/00025972419923849Search in Google Scholar
Kim H, Park M-J, Sung T-J, et al. Hemolytic disease of the newborn associated with anti-Jraalloimmunization in a twin pregnancy: the first case report in Korea. Korean J Lab Med 2010;30:511–15.Search in Google Scholar
Sasamoto N, Tomimatsu T, Nagamine K, et al. Fetal and neonatal anemia associated with anti-Jra: a case report showing a poorly hemolytic mechanism. J. Obstet Gynaecol Res 2011;37:1132–6.10.1111/j.1447-0756.2010.01477.x21481087Search in Google Scholar
Verska JJ, Larson NL. Autologous transfusion in cardiac surgery: a case report of a patient with a rare antibody. Transfusion 1973;13:219–20.10.1111/j.1537-2995.1973.tb05477.x4721075Search in Google Scholar
Yoshida H, Yurugi K, Ito K. A case of delayed hemolytic transfusion reaction due to anti-Jra. Jpn J Tranfus Med 1991; 34:528–30.Search in Google Scholar
Jowitt S, Powell H, Shwe KH, Love EM. Transfusion reaction due to anti-Jra. (abstract). Transfusion Med 1994;4(Suppl 1):49.Search in Google Scholar
Pisacka M, Prosicka M, Kralova M, et al. Six cases of anti-Jra antibody detected in one year: a probable relation with Gypsy ethnic minority from central Slovakia. (abstract). Vox Sang 2000;78(suppl):P146.Search in Google Scholar
Yuan S, Armour R, Reid A, et al. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra. Immunohematology 2005;21:97–101.10.21307/immunohematology-2019-400Search in Google Scholar
Kwon MY, Su L, Arndt P, Garratty G, Blackall DP. Clinical significance of anti-Jra: report of two cases and review of the literature. Transfusion 2004;44:197–201.10.1111/j.1537-2995.2004.00643.x14962310Search in Google Scholar
Hundric Haspl HH, Jurakovic Loncar JL, et al. The clinical significance of anti-Jra: mild or severe? (abstract). Vox Sang 2007;93(Suppl 1):208–9.Search in Google Scholar
Lewis M, Anstee DJ, Bird GWG, et al. Blood group terminology 1990. The ISBT Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 1990;58:152–69.10.1159/000461106Search in Google Scholar
Zelinski T, Coghlan G, Liu XG, Reid ME. ABCG2 null alleles define the Jr(a–) blood group phenotype. Nat Genet 2012;44:131–2.10.1038/ng.1075Search in Google Scholar
Saison C, Helias V, Balif BA, et al. Null alleles of ABCG2encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet 2012;44:174–7.10.1038/ng.1070Search in Google Scholar
Hue-Roye K, Lomas-Francis C, Coghlan G, Zelinski T, Reid ME. The JR blood group system (ISBT 032): molecular characterization of three new alleles. Transfusion 2012 Oct 15. [Epub ahead of print].10.1111/j.1537-2995.2012.03930.xSearch in Google Scholar
Hue-Roye K, Zelinski T, Cobaugh A, Lomas-Francis C, Miyazaki T, Reid ME. The JR blood group system: alleles that alter expression? (abstract). Transfusion 2013 Feb 25. [Epub ahead of print].10.1111/trf.12118Search in Google Scholar
Imai Y, Nakane M, Kage K, et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002;1:611–16.Search in Google Scholar
Kobayashi D, Ieiri I, Hirota T, et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 2005;33:94–101.10.1124/dmd.104.001628Search in Google Scholar
Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 2001;1520:234–41.10.1016/S0167-4781(01)00270-6Search in Google Scholar
Klein I, Sarkadi B, Váradi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999;1461:237–62.10.1016/S0005-2736(99)00161-3Search in Google Scholar
Woodward OM, Köttgen A, Köttgen M. ABCG transporters and disease. FEBS J 2011;278:3215–25.10.1111/j.1742-4658.2011.08171.x494737221554546Search in Google Scholar
Leimanis ML, Georges E. ABCG2 membrane transporter in mature human erythrocytes is exclusively homodimer. Biochem Biophys Res Commun 2007;354:345–50.10.1016/j.bbrc.2006.12.21917250810Search in Google Scholar
Xu J, Liu Y, Yang Y, Bates S, Zhang JT. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 2004;279:19781–9.10.1074/jbc.M31078520015001581Search in Google Scholar
Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998;95:15665–70.10.1073/pnas.95.26.15665281019861027Search in Google Scholar
Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458–64.Search in Google Scholar
Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998;58:5337–9.Search in Google Scholar
Miyake K, Mickley L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 1999;59:8–13.Search in Google Scholar
Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 2009;106:10338–42.10.1073/pnas.0901249106270091019506252Search in Google Scholar
Wielinga P, Hooijberg JH, Gunnarsdottir S, et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 2005;65:4425–30.10.1158/0008-5472.CAN-04-281015899835Search in Google Scholar
Krishnamurthy P, Xie T, Schuetz JD. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther 2007;114:345–58.10.1016/j.pharmthera.2007.02.00117368550Search in Google Scholar
Tamura A, Masato W, Saito H, et al. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol Pharmacol 2006;70:287–96.10.1124/mol.106.02355616608919Search in Google Scholar
Huls M, Russel FG, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 2009;328:3–9.10.1124/jpet.107.13222518791064Search in Google Scholar
Kusuhara H, Sugiyama Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2005;2: 73–85.10.1602/neurorx.2.1.7353932315717059Search in Google Scholar
Dauchy S, Dutheil F, Weaver RJ, et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008;107:1518–28.10.1111/j.1471-4159.2008.05720.x19094056Search in Google Scholar
Borst P, Elferink O. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537–92.10.1146/annurev.biochem.71.102301.09305512045106Search in Google Scholar
Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340–58.10.1038/sj.onc.1206938Search in Google Scholar
Natarajan K, Xie Y, Baer MR, Ross DD. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 2012;83:1084–103.10.1016/j.bcp.2012.01.002Search in Google Scholar
Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate transporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009;1:5ra11.10.1126/scitranslmed.3000237Search in Google Scholar
Tiribelli M, Fabbro D, Franzoni A, Fanin R, Damante G, Damiani D. Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. Haematologica 2012 Oct 12. [Epub ahead of print].10.3324/haematol.2012.075895Search in Google Scholar
Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. 3rd ed. San Diego, CA: Elsevier; 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Takeshita A, Watanabe H, Fijihara H, et al. Collaborative study of irregular erythrocyte antibodies in Japan: results from the Japanese study group of allo-immunity and antigen diversity in Asian populations. Transf Apher Sci 2010;43:3–8.10.1016/j.transci.2010.04.001Search in Google Scholar
Ogasawara K, Mazuda T. Characterization of Jraantibodies by monocyte phagocytosis assays and flow cytometry analysis (in Japanese). Acta Haematol Jpn 1990;53:1131–7.Search in Google Scholar
Garratty G, Arndt P, Nance S. The potential clinical significance of blood group alloantibodies to high frequency antigens (abstract). Blood 1997;10(Suppl 1):473a.Search in Google Scholar
Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247–52.10.1016/0002-9378(94)90477-4Search in Google Scholar
Arndt PA, Garratty G, Daniels G, et al. Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of erythroid progenitors. Transfus Med 2005;15:125–32.10.1111/j.0958-7578.2005.00562.x15859979Search in Google Scholar
